IMVT Stock Analysis: Buy, Sell, or Hold?
IMVT - Immunovant, Inc. Common Stock
$38.79
0.65 (1.70%)
▲
5d:
+1.44%
30d:
+25.45%
90d:
+54.54%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Distribution
None View Scanner →
Strength: 8.0/10
Get Alerted When IMVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMVT is currently trading at $38.79, which is considered extended relative to its 30-day fair value range of $30.45 to $36.52.
Technical Outlook: Technically, IMVT is in a strong uptrend. The price is approaching resistance at $39.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IMVT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.76 (+18.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMVT is in a strong uptrend. The price is approaching resistance at $39.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IMVT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.76 (+18.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$30.45 -
$36.52
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.3%
Protect Your Profits
Holding IMVT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($45.76)
Trading Range Analysis
30-Day Trading Range
$30.45 -
$36.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$34.40
Resistance Level
$39.28
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.01
Wall Street Target
$45.76
(+18.0%)
Share & Embed Analysis
Last updated: July 02, 2026 10:32 PM ET
Data refreshes hourly during market hours. Next update: 11:32 PM
Data refreshes hourly during market hours. Next update: 11:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Tiago Girao
SELL
25760 shares
2026-04-23
Jay S Stout
SELL
2754 shares
2026-04-23
Jay S Stout
SELL
10132 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
Advanced IMVT Option Strategies
Professional options setups generated by AI based on today's IMVT price and gamma walls.